Spots Global Cancer Trial Database for rapamune
Every month we try and update this database with for rapamune cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Ph II Erlotinib + Sirolimus for Pts w Recurrent Malignant Glioma Multiforme | NCT00672243 | Glioblastoma Gliosarcoma | Erlotinib + sir... | 18 Years - | Duke University | |
| Fucosylated T Cells for Graft Versus Host Disease (GVHD) Prevention | NCT02423915 | Leukemia Lymphoma | Rituximab Fludarabine Cyclophosphamid... Total Body Radi... Fucosylated Reg... Cord Blood Infu... Mycophenolate m... Sirolimus Bone Marrow Asp... G-CSF Non-Fucosylated... | 18 Years - 80 Years | M.D. Anderson Cancer Center | |
| Sirolimus for Improving Social Abilities in People With PTEN Germline Mutations | NCT06080165 | PTEN Gene Mutat... PTEN Hamartoma ... PTEN Hamartoma ... | Sirolimus Placebo | 5 Years - 45 Years | Stanford University | |
| Ph II Erlotinib + Sirolimus for Pts w Recurrent Malignant Glioma Multiforme | NCT00672243 | Glioblastoma Gliosarcoma | Erlotinib + sir... | 18 Years - | Duke University | |
| Sirolimus and Cetuximab in Advanced Malignancies | NCT00940381 | Advanced Cancer | Sirolimus Cetuximab | 18 Years - | M.D. Anderson Cancer Center | |
| Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced Cancer | NCT01087554 | Advanced Cancer | Sirolimus Vorinostat Everolimus Temsirolimus | - | M.D. Anderson Cancer Center | |
| Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced Cancer | NCT01087554 | Advanced Cancer | Sirolimus Vorinostat Everolimus Temsirolimus | - | M.D. Anderson Cancer Center | |
| Docetaxel and Sirolimus in Patients With Advanced Malignancies | NCT01054313 | Advanced Cancer | Docetaxel (Taxo... Sirolimus (Rapa... Prednisone | - | M.D. Anderson Cancer Center | |
| Lapatinib With Sirolimus or Metformin | NCT01087983 | Advanced Cancer... | Lapatinib Sirolimus Metformin | - | M.D. Anderson Cancer Center | |
| Fucosylated T Cells for Graft Versus Host Disease (GVHD) Prevention | NCT02423915 | Leukemia Lymphoma | Rituximab Fludarabine Cyclophosphamid... Total Body Radi... Fucosylated Reg... Cord Blood Infu... Mycophenolate m... Sirolimus Bone Marrow Asp... G-CSF Non-Fucosylated... | 18 Years - 80 Years | M.D. Anderson Cancer Center | |
| Sirolimus or Vorinostat and Hydroxychloroquine in Advanced Cancer | NCT01266057 | Advanced Cancer... | Hydroxychloroqu... Sirolimus Vorinostat | 18 Years - | M.D. Anderson Cancer Center | |
| A Study of the mTOR Inhibitor Rapamycin (Rapamune, Sirolimus) in Combination With Abraxane in Advanced Solid Cancers | NCT00337376 | Advanced Solid ... | Rapamune Abraxane | 18 Years - | Yale University | |
| Docetaxel and Sirolimus in Patients With Advanced Malignancies | NCT01054313 | Advanced Cancer | Docetaxel (Taxo... Sirolimus (Rapa... Prednisone | - | M.D. Anderson Cancer Center | |
| Sirolimus and Cetuximab in Advanced Malignancies | NCT00940381 | Advanced Cancer | Sirolimus Cetuximab | 18 Years - | M.D. Anderson Cancer Center | |
| Sirolimus and Cetuximab in Advanced Malignancies | NCT00940381 | Advanced Cancer | Sirolimus Cetuximab | 18 Years - | M.D. Anderson Cancer Center | |
| Sirolimus or Vorinostat and Hydroxychloroquine in Advanced Cancer | NCT01266057 | Advanced Cancer... | Hydroxychloroqu... Sirolimus Vorinostat | 18 Years - | M.D. Anderson Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
